Skip to main content

Cookies on BBB.org

We use cookies to give users the best content and online experience. By clicking “Accept All Cookies”, you agree to allow us to use all cookies. Visit our Privacy Policy to learn more.

Manage Cookies

Select a Language

Share
Business Profile

Biotechnology

EquiSeq

This business is NOT BBB Accredited.

Find BBB Accredited Businesses in Biotechnology.

About

About This Business

EquiSeq is a biotechnology company that develops and sells genetic tests for horses. For horse owners seeking to breed sound horses, EquiSeq's Myopathy Panel is a DNA test that identifies horses at risk for a muscle wasting disease. Unlike muscle biopsy, EquiSeq's DNA test is noninvasive. We just need a hair sample.

Years in Business: 11

Business Details

BBB File Opened:
5/9/2022
Business Started:
9/29/2015
Business Incorporated:
9/29/2015
Type of Entity:
Corporation
Business Management:
Dr. Paul Szauter PhD, CEO

Additional Contact Information

Principal Contacts
Dr. Paul Szauter PhD, CEO
Customer Contacts
Dr. Paul Szauter PhD, CEO
Additional Email Addresses
Primary: Email this Business
Complaint: Email this Business
Inquiry: Email this Business
Technical Support: Email this Business
Social Media
Facebook

Additional Information

Business Categories
Biotechnology

BBB Business Profiles are provided solely to assist you in exercising your own best judgment. BBB does not verify the accuracy of information provided by third parties, and does not guarantee the accuracy of any information in Business Profiles. As a matter of policy, BBB does not endorse any product, service, or business. Businesses are under no obligation to seek BBB accreditation, and some businesses are not accredited because they have not sought BBB accreditation.

When considering complaint information, please consider the company's size and volume of transactions. Note that the nature of complaints and a company’s responses to them are often more important than the number of complaints. BBB Business Profiles generally cover a three-year reporting period.